Literature DB >> 31373379

Supratotal Resection of Glioblastoma: Is Less More?

Roberto Altieri1, Antonio Melcarne1, Riccardo Soffietti2, Roberta Rudá2, Federica Franchino2, Alessia Pellerino2, Giuseppe La Rocca3, Giovanni Sabatino3, Alessandro Olivi4, Alessandro Ducati1, Pietro Zeppa1, Valentina Tardivo5, Cristina Mantovani6, Ilaria Chiovatero6, Stefania Martini6, Pasquale Dolce7, Riccardo Savastano8, Michele Maria Lanotte1, Francesco Zenga5, Diego Garbossa5.   

Abstract

BACKGROUND: A relationship between the extent of resection (EOR) and survival has been demonstrated in patients with glioblastomas (GBMs). However, despite gross total resection (GTR) of the enhancing nodule (EN), GBMs usually relapse, generally near the surgical cavity.
OBJECTIVE: The aim of this study was to determine the prognostic role of FLAIR resection of GBMs by analyzing pre- and post-operative MRIs to estimate the EOR of EN, FLAIR-hyperintense regions and total tumor volume (TTV).
METHODS: Radiologic and clinical outcomes were analyzed retrospectively. Pre- and post-operative EN volume, pre- and postoperative FLAIR volume (POFV), and pre- and postoperative TTV were analyzed. EOR was then calculated for each component. Time-dependent ROC curves and cut-off values for pre- and post-operative volumes and EOR were calculated. A Kaplan-Meier analysis with the log-rank test and Cox regression analysis were then used to analyze progression-free survival (PFS) and overall survival (OS).
RESULTS: We did not find any correlation between EOR of FLAIR-altered regions and patient survival. On the other hand, there were statistically significant relationships between the prognosis and both a preoperative EN volume less than 31.35 cm3 (p=0.032) and a postoperative EN volume less than 0.57 cm3 (p=0.015). Moreover, an EOR of EN greater than 96% was significantly associated with the prognosis (p=0.0051 for OS and p=0.022 for PFS).
CONCLUSION: Our retrospective, multi-center study suggests that survival in patients with GBM is not affected by the extent of resection of FLAIR-hyperintense areas.

Entities:  

Year:  2019        PMID: 31373379

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  10 in total

1.  Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.

Authors:  Ashish H Shah; Anil Mahavadi; Long Di; Alexander Sanjurjo; Daniel G Eichberg; Veronica Borowy; Javier Figueroa; Evan Luther; Macarena Ines de la Fuente; Alexa Semonche; Michael E Ivan; Ricardo J Komotar
Journal:  J Neurooncol       Date:  2020-07-05       Impact factor: 4.130

2.  Anatomical distribution of cancer stem cells between enhancing nodule and FLAIR hyperintensity in supratentorial glioblastoma: time to recalibrate the surgical target?

Authors:  Roberto Altieri; Giuseppe Broggi; Francesco Certo; Daniela Pacella; Giacomo Cammarata; Massimiliano Maione; Marco Garozzo; Davide Barbagallo; Michele Purrello; Rosario Caltabiano; Gaetano Magro; Giuseppe Barbagallo
Journal:  Neurosurg Rev       Date:  2022-09-28       Impact factor: 2.800

Review 3.  Supramarginal Resection for Glioblastoma: It Is Time to Set Boundaries! A Critical Review on a Hot Topic.

Authors:  Francesco Guerrini; Elena Roca; Giannantonio Spena
Journal:  Brain Sci       Date:  2022-05-16

4.  Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.

Authors:  Tito Vivas-Buitrago; Ricardo A Domingo; Shashwat Tripathi; Gaetano De Biase; Desmond Brown; Oluwaseun O Akinduro; Andres Ramos-Fresnedo; David S Sabsevitz; Bernard R Bendok; Wendy Sherman; Ian F Parney; Mark E Jentoft; Erik H Middlebrooks; Fredric B Meyer; Kaisorn L Chaichana; Alfredo Quinones-Hinojosa
Journal:  J Neurosurg       Date:  2021-06-04       Impact factor: 5.408

5.  Radiological evaluation of ex novo high grade glioma: velocity of diametric expansion and acceleration time study.

Authors:  Roberto Altieri; Francesco Certo; Giuseppe La Rocca; Antonio Melcarne; Diego Garbossa; Alberto Bianchi; Salvatore Crimi; Alessandro Pluchino; Simone Peschillo; Giuseppe M V Barbagallo
Journal:  Radiol Oncol       Date:  2020-12-03       Impact factor: 2.991

6.  High Grade Glioma Treatment in Elderly People: Is It Different Than in Younger Patients? Analysis of Surgical Management Guided by an Intraoperative Multimodal Approach and Its Impact on Clinical Outcome.

Authors:  Giuseppe Maria Vincenzo Barbagallo; Roberto Altieri; Marco Garozzo; Massimiliano Maione; Stefania Di Gregorio; Massimiliano Visocchi; Simone Peschillo; Pasquale Dolce; Francesco Certo
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

Review 7.  Peritumoral Microenvironment in High-Grade Gliomas: From FLAIRectomy to Microglia-Glioma Cross-Talk.

Authors:  Roberto Altieri; Davide Barbagallo; Francesco Certo; Giuseppe Broggi; Marco Ragusa; Cinzia Di Pietro; Rosario Caltabiano; Gaetano Magro; Simone Peschillo; Michele Purrello; Giuseppe Barbagallo
Journal:  Brain Sci       Date:  2021-02-06

8.  Predicting the true extent of glioblastoma based on probabilistic tractography.

Authors:  David Kis; Laszlo Szivos; Mark Rekecki; Bayan Salam Shukir; Adrienn Mate; Katalin Hideghety; Pal Barzo
Journal:  Front Neurosci       Date:  2022-09-21       Impact factor: 5.152

Review 9.  Fluorescence-Guided Surgery for High-Grade Gliomas: State of the Art and New Perspectives.

Authors:  Giuseppe Palmieri; Fabio Cofano; Luca Francesco Salvati; Matteo Monticelli; Pietro Zeppa; Giuseppe Di Perna; Antonio Melcarne; Roberto Altieri; Giuseppe La Rocca; Giovanni Sabatino; Giuseppe Maria Barbagallo; Fulvio Tartara; Francesco Zenga; Diego Garbossa
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

10.  Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center study.

Authors:  Seiichiro Hirono; Ko Ozaki; Masayoshi Kobayashi; Ayaka Hara; Tomohiro Yamaki; Tomoo Matsutani; Yasuo Iwadate
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.